Connect to other sites within the UBM Medica Network
Hospice Care Patients Have Fewer Hospitalizations, Lower Costs at End of Life
Cancer patients who received hospice care during the last year of life had fewer hospitalizations and lower overall costs than patients outside of hospice.
ASCO: Reform Medicaid to Improve Cancer Care for Low-Income Patients
ASCO is calling for major reforms to the Medicaid system in order to close gaps in cancer coverage and improve quality of care for low-income Americans.
Quarter of Breast Conservation Patients Require Repeat Surgery
Data from a large study found that about 25% of women who underwent breast conservation surgery for stage 0-II breast cancer had a repeat surgical intervention.
PCA3 May Have Role Predicting Prostate Biopsy Outcome
The use of a prostate cancer antigen 3 urine test could help men avoid undergoing unnecessary repeat biopsies, and predict which will be positive for cancer.
Depression, Impaired Executive Function Shortens Survival in Glioblastoma
Depressive symptoms and impaired executive functioning, both common in patients with glioblastoma, are independently associated with shorter overall survival.
Core Set of Symptoms Highlighted for Brain Tumor Patients
A core set of symptoms are common across brain tumor patients and underscore the complexity of brain tumors and their management.
Genomic Analysis Will Reshape Low-Grade Glioma Classification, Treatment
New research suggests that characterizing low-grade gliomas according to molecular markers may be a more useful approach in order to guide treatment decisions.
Adding Sargramostim to Ipilimumab Prolonged Survival in Metastatic Melanoma Trial
The addition of sargramostim to the anti-CTLA-4 ipilimumab resulted in a significant improvement in overall survival in patients with metastatic melanoma.
HDAC Inhibition With Decitabine Fails to Improve MDS, AML Outcomes
Adding the HDAC inhibitor valproic acid to decitabine did not improve outcomes in patients with myelodysplastic syndromes or acute myeloid leukemia.
Rindopepimut Vaccine With Bevacizumab Ups Survival in Recurrent Glioblastoma
The immunotherapeutic rindopepimut with bevacizumab yielded a significant survival improvement in relapsed glioblastoma patients with a EGFRvIII mutation.
By clicking Accept, you agree to become a member of the UBM Medica Community.